BIOLOGICAL PROPERTIES OF SV40 EARLY PROTEINS
SV40 早期蛋白的生物学特性
基本信息
- 批准号:3165850
- 负责人:
- 金额:$ 16.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-01-01 至 1989-07-31
- 项目状态:已结题
- 来源:
- 关键词:embryo /fetus tissue /cell culture gene expression genetic transcription hamsters immunochemistry laboratory mouse laboratory rat membrane activity membrane structure mutant oncogenes oncogenic virus protein structure radiotracer simian virus 40 tissue /cell culture transforming growth factors transforming virus tumor antigens viral leukemogenesis virus antigen virus genetics virus protein virus replication
项目摘要
The long-range goal of this laboratory is to understand the functional
interactions between a tumor virus and the host cell. The approach has
been to define the biological functions expressed by the SV40 transforming
protein, large tumor antigen (T-ag), in infected and transformed cells.
Our efforts during the previous funding period focused on characterizing
the plasma membrane-associated form of SV40 T-ag and analyzing a viral
mutant that encoded a cytoplasmic T-ag (cT-ag) defective for nuclear
transport. We showed that surface T-ag is associated with host protein p53
in the membrane of transformed cells, that the complex is rapidly turned
over in the membrane, that the conformation in the membrane exposes both
amino and carboxy termini of T-ag on the exterior of the cell, and that the
expression of surface T-ag correlates with cell growth. Studies of the
nuclear-transport-defective viral mutant succeeded in identifying the
single amino acid change responsible for blocking nuclear transport of
T-ag. Finally, we found that T-ag is modified by glycosylation. These
efforts culminated in a perspective that forms the basis of the current
proposal, namely that the surface-associated form of SV40 T-ag is
functionally important. Proposed objectives are logical extensions of our
previous studies and are timely in the context of current thinking
regarding possible molecular mechanisms in carcinogenesis.
The following specific aims are proposed. (1) To categorize into
complementation groups the transformation-related functions expressed by
T-ag. The approach will include co-transfection/transformation assays
using the mutant cT-ag-encoding plasmid and known cloned oncogenes in
primary and immortalized host cells. (2) To further examine the observed
relationship between surface T-ag expression and cell growth. (3) To test
the hypothesis that surface-associated T-ag may be functioning in a growth
factor pathway by mimicking an "activated" growth factor receptor.
Internalization of surface T-ag and processing by lysosomal proteases will
be sought, and the possible requirement of complex formation with cellular
protein p53 to generate an "active" T-ag conformation examined. (4) To
further characterize the glycosylation modification of T-ag, especially
with respect to mapping the glycosylation sites on the polypeptide. T-ag
may be a good model for O-glycoproteins in general. Finally, (5) To study
the intracellular trafficking of T-ag. Special emphasis will be placed on
determining the sites of T-ag synthesis and O-glycosylation in the cell, as
well as investigating the sorting that separates T-ag molecules destined
for nuclear and surface localizations. These studies should yeild
important insights into the biological functioning of a prototype viral
transforming protein and broaden our understanding of molecular mechanisms
involved in cellular transformation.
这个实验室的长期目标是了解
肿瘤病毒和宿主细胞之间的相互作用。 该方法具有
定义SV40转化表达的生物学功能
蛋白质,大肿瘤抗原(T-ag),在感染和转化细胞。
我们在上一个供资期间的工作重点是描述
SV40 T-ag的质膜结合形式和分析病毒
一种编码细胞质T-ag(cT-ag)的突变体,
运输 我们发现表面T-ag与宿主蛋白p53相关,
在转化细胞的膜中,复合物迅速转变为
在膜上,膜上的构象暴露了
氨基和羧基末端的T-ag的细胞的外部,
表面T-ag的表达与细胞生长相关。 的研究
核转运缺陷型病毒突变体成功地鉴定了
单个氨基酸的变化,负责阻断核转运
T-ag 最后,我们发现T-ag被糖基化修饰。 这些
这些努力最终形成了一种观点,
建议,即SV40 T-ag的表面结合形式是
功能重要。 拟议的目标是我们的逻辑延伸,
以前的研究,并及时在当前的思维背景下,
关于致癌的可能分子机制。
提出了以下具体目标。 (1)归入
互补组的转换相关的功能表示,
T-ag 该方法将包括共转染/转化测定
使用突变的cT-ag编码质粒和已知的克隆癌基因,
原代和永生化宿主细胞。 (2)为了进一步研究观察到的
表面T-ag表达与细胞生长的关系。 (3)测试
假设表面相关的T-ag可能在生长中起作用,
通过模拟"活化的"生长因子受体来激活生长因子途径。
表面T-ag的内化和溶酶体蛋白酶的加工将
可能需要与细胞形成复合物,
蛋白p53产生"活性"的T-ag构象检查。 (4)到
进一步表征T-ag的糖基化修饰,特别是
关于多肽上糖基化位点的作图。 t-AG
可能是O-糖蛋白的一个很好的模型。 (5)研究
T-ag的细胞内运输。 将特别强调
确定细胞中T-ag合成和O-糖基化的位点,
以及研究T-ag分子的分类,
用于核和表面定位。 这些研究应该会产生
对原型病毒的生物学功能的重要见解
转化蛋白,拓宽我们对分子机制的理解
参与细胞转化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANET S BUTEL其他文献
JANET S BUTEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JANET S BUTEL', 18)}}的其他基金
相似海外基金
CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
- 批准号:
2339849 - 财政年份:2024
- 资助金额:
$ 16.21万 - 项目类别:
Continuing Grant
CAREER: Scalable algorithms for regularized and non-linear genetic models of gene expression
职业:基因表达的正则化和非线性遗传模型的可扩展算法
- 批准号:
2336469 - 财政年份:2024
- 资助金额:
$ 16.21万 - 项目类别:
Continuing Grant
CAREER: Epigenetic Regulation of Gene Expression in Engineered Prokaryotes
职业:工程原核生物基因表达的表观遗传调控
- 批准号:
2338573 - 财政年份:2024
- 资助金额:
$ 16.21万 - 项目类别:
Continuing Grant
MFB: RNA modifications of frameshifting stimulators: cellular platforms to engineer gene expression by computational mutation predictions and functional experiments
MFB:移码刺激器的RNA修饰:通过计算突变预测和功能实验来设计基因表达的细胞平台
- 批准号:
2330628 - 财政年份:2024
- 资助金额:
$ 16.21万 - 项目类别:
Standard Grant
22-BBSRC/NSF-BIO Building synthetic regulatory units to understand the complexity of mammalian gene expression
22-BBSRC/NSF-BIO 构建合成调控单元以了解哺乳动物基因表达的复杂性
- 批准号:
BB/Y008898/1 - 财政年份:2024
- 资助金额:
$ 16.21万 - 项目类别:
Research Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
- 批准号:
DP240102119 - 财政年份:2024
- 资助金额:
$ 16.21万 - 项目类别:
Discovery Projects
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
2024 CIHR NIF (ECR) 申请:研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
491942 - 财政年份:2023
- 资助金额:
$ 16.21万 - 项目类别:
Regulation of gene expression by the La and La-related proteins
La 和 La 相关蛋白对基因表达的调节
- 批准号:
489704 - 财政年份:2023
- 资助金额:
$ 16.21万 - 项目类别:
Operating Grants
Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
- 批准号:
494272 - 财政年份:2023
- 资助金额:
$ 16.21万 - 项目类别:
Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 16.21万 - 项目类别: